ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
103.854 IP-LS
Project title
Development of brain-penetrant MNK inhibitors

Texts for this project
 GermanFrenchItalianEnglish
Key words
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen

Inserted texts


CategoryText
Key words
(English)
Life sciences, Pharmaceuticals
Abstract
(English)
MAP-kinase interacting kinases (MNKs) are a novel target for the treatment of autism spectrum disorders. We aim to develop a brain-penetrant, small molecule inhibitor that selectively targets MNKs and alleviates the core symptoms of autism.